{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:45:51Z","timestamp":1789764351043,"version":"4.0.1"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1212\/con.0000000000000560","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T13:59:10Z","timestamp":1518530350000},"page":"130-149","source":"Crossref","is-referenced-by-count":12,"title":["Leukodystrophies"],"prefix":"10.1212","volume":"24","author":[{"given":"Amy T.","family":"Waldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2015.01.006"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000343049.00540.c8"},{"issue":"8","key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/brain\/120.8.1485","article-title":"Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy","volume":"120","author":"Moser HW","year":"1997","unstructured":"Moser HW. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 1997;120(8):1485\u20131508. doi:10.1093\/brain\/120.8.1485.","journal-title":"Brain"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.1227"},{"issue":"9","key":"e_1_3_2_6_2","first-page":"1761","article-title":"Adrenoleukodystrophy: a scoring method for brain MR observations","volume":"15","author":"Loes D","year":"1994","unstructured":"Loes D Hite S Moser H. Adrenoleukodystrophy: a scoring method for brain MR observations. AJNR Am J Neuroradiol 1994;15(9):1761\u20131766.","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000079050.91337.83"},{"issue":"1","key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ymgme.2006.05.001","article-title":"Combined liquid chromatography-tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings","volume":"89","author":"Hubbard WC","year":"2006","unstructured":"Hubbard WC Moser AB Tortorelli S. Combined liquid chromatography-tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings. Mol Genet Metab 2006;89(1\u20132):185\u2013187. doi:10.1016\/j.ymgme.2006.05.001.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ymgme.2009.03.010","article-title":"Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography\u2013tandem mass spectrometric (LC\u2013MS\/MS) method","volume":"97","author":"Hubbard WC","year":"2009","unstructured":"Hubbard WC Moser AB Liu AC. Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography\u2013tandem mass spectrometric (LC\u2013MS\/MS) method. Mol Genet Metab 2009;97(3):212\u2013220. doi:10.1016\/j.ymgme.2009.03.010.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ymgme.2014.11.013","article-title":"Streamlined determination of lysophosphatidylcholines in dried blood spots for newborn screening of X-linked adrenoleukodystrophy","volume":"114","author":"Turgeon CT","year":"2015","unstructured":"Turgeon CT Moser AB M\u00f8rkrid L. Streamlined determination of lysophosphatidylcholines in dried blood spots for newborn screening of X-linked adrenoleukodystrophy. Mol Genet Metab 2015;114(1):46\u201350. doi:10.1016\/j.ymgme.2014.11.013.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.bmt.1705571","article-title":"N-acetyl-L-cysteine improves outcome of advanced cerebral adrenoleukodystrophy","volume":"39","author":"Tolar J","year":"2007","unstructured":"Tolar J Orchard P Bjoraker K. N-acetyl-L-cysteine improves outcome of advanced cerebral adrenoleukodystrophy. Bone Marrow Transplant 2007;39(4):211\u2013215. doi:10.1038\/sj.bmt.1705571.","journal-title":"Bone Marrow Transplant"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1700554"},{"issue":"7","key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archneur.62.7.1073","article-title":"Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo\u2019s oil","volume":"62","author":"Moser HW","year":"2005","unstructured":"Moser HW Raymond G V Lu S-E. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo\u2019s oil. Arch Neurol 2005;62(7):1073\u20131080. doi:10.1001\/archneur.62.7.1073.","journal-title":"Arch Neurol"},{"key":"e_1_3_2_14_2","first-page":"1993","volume-title":"GeneReviews","author":"Wenger DA","year":"2011","unstructured":"Wenger DA. Krabbe disease. In: Pagon RA Adam MP Ardinger HH, eds. GeneReviews. Seattle, WA: University of Washington, Seattle, 2011:1993\u20132017. ncbi.nlm.nih.gov\/pubmed\/20301416. Accessed December 4, 2017."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-8994(02)00489-7"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2013.10.001"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2012.02.023"},{"issue":"12","key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/gim.2016.35","article-title":"Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State","volume":"18","author":"Wasserstein MP","year":"2016","unstructured":"Wasserstein MP Andriola M Arnold G. Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State. Genet Med 2016;18(12):1235\u20131243. doi:10.1038\/gim.2016.35.","journal-title":"Genet Med"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cca.2013.01.017","article-title":"Determination of psychosine concentration in dried blood spots from newborns that were identified via newborn screening to be at risk for Krabbe disease","volume":"419","author":"Chuang WL","year":"2013","unstructured":"Chuang WL Pacheco J Zhang XK. Determination of psychosine concentration in dried blood spots from newborns that were identified via newborn screening to be at risk for Krabbe disease. Clin Chim Acta 2013;419:73\u201376. doi:10.1016\/j.cca.2013.01.017.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10545-015-9822-z","article-title":"Measurement of psychosine in dried blood spots\u2013a possible improvement to newborn screening programs for Krabbe disease","volume":"38","author":"Turgeon CT","year":"2015","unstructured":"Turgeon CT Orsini JJ Sanders KA. Measurement of psychosine in dried blood spots\u2013a possible improvement to newborn screening programs for Krabbe disease. J Inherit Metab Dis 2015;38(5):923\u2013929. doi:10.1007\/s10545-015-9822-z.","journal-title":"J Inherit Metab Dis"},{"issue":"11","key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/jnr.23793","article-title":"Can psychosine and galactocerebrosidase activity predict early-infantile Krabbe\u2019s disease presymptomatically?","volume":"94","author":"Carter RL","year":"2016","unstructured":"Carter RL Wrabetz L Jalal K. Can psychosine and galactocerebrosidase activity predict early-infantile Krabbe\u2019s disease presymptomatically? J Neurosci Res 2016;94(11):1084\u20131093. doi:10.1002\/jnr.23793.","journal-title":"J Neurosci Res"},{"issue":"20","key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa042604","article-title":"Transplantation of umbilical-cord blood in babies with Infantile Krabbe\u2019s disease","volume":"352","author":"Escolar ML","year":"2005","unstructured":"Escolar ML Poe MD Provenzale JM. Transplantation of umbilical-cord blood in babies with Infantile Krabbe\u2019s disease. N Engl J Med 2005;352(20):2069\u20132081. doi:10.1056\/NEJMoa042604.","journal-title":"N Engl J Med"},{"issue":"13","key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0000000000004418","article-title":"Developmental outcomes of cord blood transplantation for Krabbe disease","volume":"89","author":"Wright MD","year":"2017","unstructured":"Wright MD Poe MD DeRenzo A. Developmental outcomes of cord blood transplantation for Krabbe disease. Neurology 2017;89(13):1\u20138. doi:10.1212\/WNL.0000000000004418.","journal-title":"Neurology"},{"issue":"2","key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/jnnp.38.2.169","article-title":"Peripheral neuropathy detected on electrophysiological study as first manifestation of metachromatic leucodystrophy in infancy","volume":"38","author":"Cruz Martinez A","year":"1975","unstructured":"Cruz Martinez A Ferrer MT Fueyo E Galdos AL. Peripheral neuropathy detected on electrophysiological study as first manifestation of metachromatic leucodystrophy in infancy. J Neurol Neurosurg Psychiatry 1975;38(2):169\u2013174. doi:10.1136\/jnnp.38.2.169.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejpn.2008.04.011","article-title":"Peripheral neuropathy as the sole initial finding in three children with infantile metachromatic leukodystrophy","volume":"13","author":"Haberlandt E","unstructured":"Haberlandt E Scholl-B\u00fcrgi S Neuberger J. Peripheral neuropathy as the sole initial finding in three children with infantile metachromatic leukodystrophy. Eur J Paediatr Neurol 13(3):257\u2013260. doi:10.1016\/j.ejpn.2008.04.011.","journal-title":"Eur J Paediatr Neurol"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002811"},{"issue":"5","key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00247-012-2523-y","article-title":"Gallbladder polyposis in metachromatic leukodystrophy","volume":"43","author":"Agarwal A","year":"2013","unstructured":"Agarwal A Shipman PJ. Gallbladder polyposis in metachromatic leukodystrophy. Pediatr Radiol 2013;43(5):631\u2013633. doi:10.1007\/s00247-012-2523-y.","journal-title":"Pediatr Radiol"},{"issue":"1","key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pediatrneurol.2013.03.019","article-title":"Leukodystrophy: when gallbladder offers a clue to diagnosis","volume":"49","author":"Shah S","year":"2013","unstructured":"Shah S Ghosh S Nagarajan L. Leukodystrophy: when gallbladder offers a clue to diagnosis. Pediatr Neurol 2013;49(1):68\u201369. doi:10.1016\/j.pediatrneurol.2013.03.019.","journal-title":"Pediatr Neurol"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1739"},{"key":"e_1_3_2_30_2","first-page":"1993","volume-title":"GeneReviews","author":"Fluharty AL","year":"2014","unstructured":"Fluharty AL. Arylsulfatase A deficiency. In: Pagon RA Adam MP Ardinger HH, eds. GeneReviews. Seattle, WA: University of Washington, Seattle; 2014:1993\u20132017. ncbi.nlm.nih.gov\/pubmed\/20301309. Accessed December 4, 2017."},{"issue":"1","key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1373\/clinchem.2015.245159","article-title":"Sulfatide analysis by mass spectrometry for screening of metachromatic leukodystrophy in dried blood and urine samples","volume":"62","author":"Spacil Z","year":"2016","unstructured":"Spacil Z Babu Kumar A Liao HC. Sulfatide analysis by mass spectrometry for screening of metachromatic leukodystrophy in dried blood and urine samples. Clin Chem 2016;62(1):279\u2013286. doi:10.1373\/clinchem.2015.245159.","journal-title":"Clin Chem"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.2067"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.01.010"},{"issue":"1","key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13023-015-0313-y","article-title":"Long-term outcomes after allogeneic hematopoietic stem celltransplantation for metachromatic leukodystrophy: the largest single-institution cohort report","volume":"10","author":"Boucher AA","year":"2015","unstructured":"Boucher AA Miller W Shanley R. Long-term outcomes after allogeneic hematopoietic stem celltransplantation for metachromatic leukodystrophy: the largest single-institution cohort report. Orphanet J Rare Dis 2015;10(1):94. doi:10.1186\/s13023-015-0313-y.","journal-title":"Orphanet J Rare Dis"},{"issue":"6148","key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi A","year":"2013","unstructured":"Biffi A Montini E Lorioli L. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 2013;341(6148):1233158. doi:10.1126\/science.1233158.","journal-title":"Science"},{"issue":"10043","key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(16)30374-9","article-title":"Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial","volume":"388","author":"Sessa M","year":"2016","unstructured":"Sessa M Lorioli L Fumagalli F. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial. Lancet 2016;388(10043):476\u2013487. doi:10.1016\/S0140-6736(16)30374-9.","journal-title":"Lancet"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.36887"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410150109"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket372"},{"issue":"11","key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/jmg.32.11.881","article-title":"The Aicardi-Gouti\u00e8res syndrome (familial, early onset encephalopathy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis)","volume":"32","author":"Tolmie JL","year":"1995","unstructured":"Tolmie JL Shillito P Hughes-Benzie R Stephenson JB. The Aicardi-Gouti\u00e8res syndrome (familial, early onset encephalopathy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis). J Med Genet 1995;32(11):881\u2013884. doi:10.1136\/jmg.32.11.881.","journal-title":"J Med Genet"},{"issue":"8","key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1600-0560.2007.00900.x","article-title":"Cutaneous histopathological findings of Aicardi-Goutieres syndrome, overlap with chilblain lupus","volume":"35","author":"Kolivras A","year":"2008","unstructured":"Kolivras A Aeby A Crow YJ. Cutaneous histopathological findings of Aicardi-Goutieres syndrome, overlap with chilblain lupus. J Cutan Pathol 2008;35(8):774\u2013778. doi:10.1111\/j.1600-0560.2007.00900.x.","journal-title":"J Cutan Pathol"},{"issue":"1","key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-0030-1255059","article-title":"Chilblains as a diagnostic sign of Aicardi-Goutieres syndrome","volume":"41","author":"Abdel-Salam GMH","year":"2010","unstructured":"Abdel-Salam GMH El-Kamah GY Rice GI. Chilblains as a diagnostic sign of Aicardi-Goutieres syndrome. Neuropediatrics 2010;41(1):18\u201323. doi:10.1055\/s-0030-1255059.","journal-title":"Neuropediatrics"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002228"},{"issue":"3","key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ajmg.a.36360","article-title":"Bilateral striatal necrosis in two subjects with Aicardi-Goutieres syndrome due to mutations in ADAR1 (AGS6)","volume":"164","author":"La Piana R","year":"2014","unstructured":"La Piana R Uggetti C Olivieri I. Bilateral striatal necrosis in two subjects with Aicardi-Goutieres syndrome due to mutations in ADAR1 (AGS6). Am J Med Genet A 2014;164A(3):815\u2013819. doi:10.1002\/ajmg.a.36360.","journal-title":"Am J Med Genet A"},{"issue":"10","key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1177\/0883073814562252","article-title":"Early-onset Aicardi-Goutieres syndrome: magnetic resonance imaging (MRI) pattern recognition","volume":"30","author":"Vanderver A","year":"2015","unstructured":"Vanderver A Prust M Kadom N. Early-onset Aicardi-Goutieres syndrome: magnetic resonance imaging (MRI) pattern recognition. J Child Neurol 2015;30(10):1343\u20131348. doi:10.1177\/0883073814562252.","journal-title":"J Child Neurol"},{"issue":"5","key":"e_1_3_2_46_2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1212\/01.WNL.0000082726.08631.E7","article-title":"Cerebrospinal fluid pterins and folates in Aicardi-Gouti\u00e8res syndrome: a new phenotype","volume":"61","author":"Blau N","year":"2003","unstructured":"Blau N Bonaf\u00e9 L Kr\u00e4geloh-Mann I. Cerebrospinal fluid pterins and folates in Aicardi-Gouti\u00e8res syndrome: a new phenotype. Neurology 2003;61(5):642\u2013647. doi:10.1212\/01.WNL.0000082726.08631.E7.","journal-title":"Neurology"},{"issue":"1","key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12115","article-title":"Therapies in Aicardi-Goutieres syndrome","volume":"175","author":"Crow YJ","year":"2014","unstructured":"Crow YJ Vanderver A Orcesi S. Therapies in Aicardi-Goutieres syndrome. Clin Exp Immunol 2014;175(1):1\u20138. doi:10.1111\/cei.12115.","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1023\/A:1021211520034","article-title":"Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis","volume":"25","author":"Clayton PT","year":"2002","unstructured":"Clayton PT Verrips A Sistermans E. Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis. J Inherit Metab Dis 2002;25(6):501\u2013513. doi:10.1023\/A:1021211520034.","journal-title":"J Inherit Metab Dis"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.217.3.r00dc03869"},{"issue":"4","key":"e_1_3_2_50_2","first-page":"1","article-title":"Cerebrotendinous xanthomatosis-he spectrum of imaging findings","volume":"7","author":"Pudhiavan A","year":"2013","unstructured":"Pudhiavan A Agrawal A Chaudhari S Shukla A. Cerebrotendinous xanthomatosis-he spectrum of imaging findings. J Radiol Case Rep 2013;7(4):1\u20139. doi:10.3941\/jrcr.v7i4.1338.","journal-title":"J Radiol Case Rep"},{"key":"e_1_3_2_51_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ymgmr.2016.02.002","article-title":"Update on newborn dried bloodspot testing for cerebrotendinous xanthomatosis: an available high-throughput liquid-chromatography tandem mass spectrometry method","volume":"7","author":"Bleyle L","year":"2016","unstructured":"Bleyle L Huidekoper HH Vaz FM. Update on newborn dried bloodspot testing for cerebrotendinous xanthomatosis: an available high-throughput liquid-chromatography tandem mass spectrometry method. Mol Genet Metab Reports 2016;7:11\u201315. doi:10.1016\/j.ymgmr.2016.02.002.","journal-title":"Mol Genet Metab Reports"},{"issue":"1","key":"e_1_3_2_52_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cca.2007.01.016","article-title":"High-throughput urine screening for Smith-Lemli-Opitz syndrome and cerebrotendinous xanthomatosis using negative electrospray tandem mass spectrometry","volume":"380","author":"Pitt JJ","year":"2007","unstructured":"Pitt JJ. High-throughput urine screening for Smith-Lemli-Opitz syndrome and cerebrotendinous xanthomatosis using negative electrospray tandem mass spectrometry. Clin Chim Acta 2007;380(1\u20132):81\u201388. doi:10.1016\/j.cca.2007.01.016.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"e_1_3_2_53_2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10545-014-9765-9","article-title":"Screening for cerebrotendinous xanthomatosis","volume":"38","author":"Pitt JJ","year":"2015","unstructured":"Pitt JJ Peters H. Screening for cerebrotendinous xanthomatosis. J Inherit Metab Dis 2015;38(2):369. doi:10.1007\/s10545-014-9765-9.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"e_1_3_2_54_2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.metabol.2003.12.003","article-title":"Hydrophilic 7-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis","volume":"53","author":"Batta AK","year":"2004","unstructured":"Batta AK Salen G Tint GS. Hydrophilic 7-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis. Metabolism 2004;53(5):556\u2013562. doi:10.1016\/j.metabol.2003.12.003.","journal-title":"Metabolism"},{"issue":"3","key":"e_1_3_2_55_2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/WNF.0b013e318288076a","article-title":"Neurological outcome in cerebrotendinous xanthomatosis treated with chenodeoxycholic acid: early versus late diagnosis","volume":"36","author":"Yahalom G","year":"2013","unstructured":"Yahalom G Tsabari R Molshatzki N. Neurological outcome in cerebrotendinous xanthomatosis treated with chenodeoxycholic acid: early versus late diagnosis. Clin Neuropharmacol 2013;36(3):78\u201383. doi:10.1097\/WNF.0b013e318288076a.","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"e_1_3_2_56_2","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1007\/s10545-008-0815-z","article-title":"Prospective treatment of cerebrotendinous xanthomatosis with cholic acid therapy","volume":"31","author":"Pierre G","year":"2008","unstructured":"Pierre G Setchell K Blyth J. Prospective treatment of cerebrotendinous xanthomatosis with cholic acid therapy. J Inherit Metab Dis 2008;31(suppl 2):S241\u2013S245. doi:10.1007\/s10545-008-0815-z.","journal-title":"J Inherit Metab Dis"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00132979-201802000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:06:54Z","timestamp":1752156414000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/CON.0000000000000560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1212\/CON.0000000000000560"],"URL":"https:\/\/doi.org\/10.1212\/con.0000000000000560","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"value":"1080-2371","type":"print"},{"value":"1538-6899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}